0000899243-20-032772.txt : 20201204
0000899243-20-032772.hdr.sgml : 20201204
20201204173807
ACCESSION NUMBER: 0000899243-20-032772
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201203
FILED AS OF DATE: 20201204
DATE AS OF CHANGE: 20201204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daniel Jennifer
CENTRAL INDEX KEY: 0001797725
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39206
FILM NUMBER: 201370809
MAIL ADDRESS:
STREET 1: SCHRODINGER, INC.
STREET 2: 120 WEST 45TH STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Schrodinger, Inc.
CENTRAL INDEX KEY: 0001490978
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 954284541
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 503-299-1150
MAIL ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-03
0
0001490978
Schrodinger, Inc.
SDGR
0001797725
Daniel Jennifer
C/O SCHRODINGER, INC.
120 WEST 45TH STREET, 17TH FLOOR
NEW YORK
NY
10036
0
1
0
0
See Remarks
Common Stock
2020-12-03
4
M
0
1923
4.34
A
8611
D
Common Stock
2020-12-03
4
M
0
10033
3.07
A
18644
D
Common Stock
2020-12-03
4
S
0
5289
65.0896
D
13355
D
Common Stock
2020-12-03
4
S
0
6667
66.0049
D
6688
D
Stock Option (right to buy)
4.34
2020-12-03
4
M
0
1923
0.00
D
2028-11-29
Common Stock
1923
14296
D
Stock Option (right to buy)
3.07
2020-12-03
4
M
0
10033
0.00
D
2027-04-07
Common Stock
10033
36788
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.59 to $65.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (3) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.60 to $66.47, inclusive.
This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022.
This option was granted on April 7, 2017. The shares underlying the option are scheduled to vest in equal yearly installments from February 22, 2017 through February 22, 2021.
Senior Vice President and Chief Human Resources Officer
/s/ Donald Shum, as attorney-in-fact for Jennifer Daniel
2020-12-04